Inactive Instrument
Quest PharmaTech Inc Stock Toronto S.E.
Stocks
QPT
CA74836M1068
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 3.38M 2.44M 2.09M 1.96M 1.79M 232M 3.4M 23.22M 9M 117M 9.15M 8.95M 388M | P/E 2025 |
-3.29x | P/E 2026 | 1.18x |
|---|---|---|---|---|---|
| Enterprise Value | 4.37M 3.15M 2.7M 2.53M 2.31M 300M 4.39M 29.99M 11.62M 151M 11.81M 11.56M 501M | EV / Sales 2025 |
-
| EV / Sales 2026 | - |
| Free-Float |
83.12% | Yield 2025 * |
-
| Yield 2026 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 17/06/2004 | |
Pierre Vermette
DFI | Director of Finance/CFO | - | 01/01/2005 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 17/06/2004 | |
J. Lievonen
CHM | Chairman | - | 05/07/2021 |
Jeffrey Shon
BRD | Director/Board Member | - | 05/07/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -15.38% | - | - | 2.44M | |
| -0.32% | -0.14% | +2.20% | +23.03% | 50.96B | |
| +1.92% | +0.36% | +477.97% | +550.09% | 46.18B | |
| -0.15% | -0.28% | +21.65% | +89.41% | 42.73B | |
| +0.81% | +4.91% | +39.28% | +19.41% | 43.04B | |
| -2.27% | -3.02% | +14.22% | +51.50% | 33.48B | |
| +0.81% | +1.77% | +31.91% | +138.26% | 17.28B | |
| -1.08% | -3.61% | - | - | 16.43B | |
| -0.38% | -0.38% | +11.33% | +28.07% | 14.73B | |
| -0.85% | +1.76% | +80.26% | +47.26% | 14.09B | |
| Average | -0.39% | +1.33% | +84.85% | +118.38% | 30.99B | |
| Weighted average by Cap. | -0.38% | +1.16% | +103.34% | +138.76% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | - | - |
| Net income | -1.8M -1.3M -1.11M -1.04M -954K -124M -1.81M -12.37M -4.79M -62.41M -4.87M -4.76M -207M | 5M 3.6M 3.09M 2.9M 2.65M 343M 5.02M 34.32M 13.3M 173M 13.52M 13.22M 574M |
| Net Debt | 795K 572K 491K 461K 421K 54.6M 799K 5.46M 2.12M 27.55M 2.15M 2.1M 91.23M | 986K 710K 609K 572K 522K 67.7M 990K 6.77M 2.62M 34.15M 2.67M 2.61M 113M |
Employees
-
